Understanding how betacoronaviruses affect the immune system

Betacoronaviruses: activation and antagonism of host innate immune responses

NIH-funded research University of Pennsylvania · NIH-11077193

This study is looking at how certain coronaviruses, like the ones that cause COVID-19 and MERS, manage to dodge our immune system and make us sick, with the goal of finding new ways to treat and prevent these viruses in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11077193 on NIH RePORTER

What this research studies

This research investigates how human betacoronaviruses, such as SARS-CoV-2 and MERS-CoV, interact with the host's immune responses. The team aims to identify the mechanisms by which these viruses evade the immune system and cause disease, focusing on the role of specific proteins and pathways involved in inflammation and antiviral responses. By studying these interactions, the research seeks to develop new therapeutic strategies to combat current and future coronavirus outbreaks.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have been infected with or are at risk of infection from betacoronaviruses, particularly those with severe respiratory symptoms.

Not a fit: Patients with non-respiratory illnesses or those not affected by betacoronaviruses may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective treatments for infections caused by betacoronaviruses, improving patient outcomes.

How similar studies have performed: Previous research has shown promise in understanding immune responses to coronaviruses, indicating that this approach could yield valuable insights.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.